1 Min Read
March 21 (Reuters) - Jubilant Life Sciences Ltd:
* Board of Jubilant Pharma has approved to negotiate a potential acquisition of a specialty pharma business in U.S. Source text: bit.ly/2nMv0o8 Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.